Trial Parameters
Condition Preeclampsia
Sponsor Charite University, Berlin, Germany
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex FEMALE
Min Age 18 Years
Max Age 60 Years
Start Date 2022-04-04
Completion 2025-04
Brief Summary
Investigation of cardiovascular risk 5-15 years after early or late-onset preeclampsia by adenosine stress Magnetic Resonance Imaging and non-invasive methods like retinal vessel analysis, skin measurement of advanced glycation end products, flow-mediated dilation or pulse wave analysis in comparison to women after healthy pregnancies.
Eligibility Criteria
Inclusion Criteria: * Women * 18-60 years * 5-15 years postpartum Exclusion Criteria: * Atrioventricular block, chronic obstructive pulmonary disease, bronchial asthma * Pregnancy and/or active breastfeeding * Glaucoma disease, epilepsy * In addition for MRI: metal implants, electric devices, intolerance of contrast media, claustrophobia, renal or hepatic dysfunction (GFR \< 30 ml/min)